1. Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020;112:102473. [
Link] [
DOI:10.1016/j.jaut.2020.102473] [
PMID] [
PMCID]
2. Vetter P, Vu DL, L'Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Clinical features of covid-19. BMJ. 2020;369:m1470. [
Link] [
DOI:10.1136/bmj.m1470] [
PMID]
3. Rodriguez-Morales AJ, Bonilla-Aldana DK, Balbin-Ramon GJ, Rabaan AA, Sah R, Paniz-Mondolfi A, et al. History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic. Infez Med. 2020;28(1):3-5. [
Link]
4. Sonkar C, Kashyap D, Varshney N, Baral B, Jha HC. Impact of gastrointestinal symptoms in COVID-19: A molecular approach. SN Compr Clin Med.2020;4:1-12. [
Link] [
DOI:10.1007/s42399-020-00619-z] [
PMID] [
PMCID]
5. Al Sulami AA, Al Taee AMR, Juma'a MG. Isolation and identification of Helicobacter pylori from drinking water in Basra governorate, Iraq. East Mediterr Health J. 2020;16(9):920-5. [
Link] [
DOI:10.26719/2010.16.9.920]
6. Mezmale L, Coelho LG, Bordin D, Leja M. Review: Epidemiology of helicobacter pylori. Helicobacter. 2020;25(51):e12734. [
Link] [
DOI:10.1111/hel.12734] [
PMID]
7. Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, et al. Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020;10(1):27. [
Link] [
DOI:10.3390/cells10010027] [
PMID] [
PMCID]
8. Balamtekin N, Artuk C, Arslan M, Gülşen M. The effect of helicobacter pylori on the presentation and clinical course of coronavirus disease 2019 infection. J Pediatr Gastroenterol Nutr. 2021;72(4):511-3. [
Link] [
DOI:10.1097/MPG.0000000000003005] [
PMID] [
PMCID]
9. Abate BB, Kassie AM, Kassaw MW, Aragie TG, Masresha SA. Sex difference in coronavirus disease (COVID-19): A systematic review and meta-analysis. BMJ Open. 2020;10(10):e040129. [
Link] [
DOI:10.1136/bmjopen-2020-040129] [
PMID] [
PMCID]
10. Kushwaha S, Khanna P, Rajagopal V, Kiran T. Biological attributes of age and gender variations in Indian COVID-19 cases: A retrospective data analysis. Clin Epidemiol Glob Health. 2021;11:100788. [
Link] [
DOI:10.1016/j.cegh.2021.100788] [
PMID] [
PMCID]
11. Peckham H, De Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:6317. [
Link] [
DOI:10.1038/s41467-020-19741-6] [
PMID] [
PMCID]
12. Pradhan A, Olsson PE. Sex differences in severity and mortality from COVID-19: Are males more vulnerable? Biol Sex Differ. 2020;11(1):53. [
Link] [
DOI:10.1186/s13293-020-00330-7] [
PMID] [
PMCID]
13. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626-38. [
Link] [
DOI:10.1038/nri.2016.90] [
PMID]
14. Cai KC, Van Mil S, Murray E, Mallet JF, Matar C, Ismail N. Age and sex differences in immune response following LPS treatment in mice. Brain Behav Immun. 2016;58:327-37. [
Link] [
DOI:10.1016/j.bbi.2016.08.002] [
PMID]
15. Naoum FA, Ruiz ALZ, Martin FHDO, Brito THG, Hassem V, Oliveira MGDL. Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID‐19. Int J Lab Hematol. 2021;43(S1):124-8. [
Link] [
DOI:10.1111/ijlh.13395] [
PMID] [
PMCID]
16. Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 202;26(8):1063-8. [
Link] [
DOI:10.1016/j.cmi.2020.03.032] [
PMID] [
PMCID]
17. Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H. Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: a retrospective study. Liver Int. 2020;40(6):1321-6. [
Link] [
DOI:10.1111/liv.14449] [
PMID] [
PMCID]
18. Tanni F, Akker E, Zaman MM, Figueroa N, Tharian B, Hupart KH. Eosinopenia and COVID-19. J Osteopath Assoc Med. 2020;120(8):504-8. [
Link] [
DOI:10.7556/jaoa.2020.091] [
PMID]
19. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389-99. [
Link] [
DOI:10.1080/10408363.2020.1770685] [
PMID] [
PMCID]
20. Henry BM. COVID-19, ECMO, and lymphopenia: A word of caution. Lancet Respir Med. 2020;8(4):e24. [
Link] [
DOI:10.1016/S2213-2600(20)30119-3]
21. Zhang M, Feng C, Zhang X, Hu S, Zhang Y, Min M, et al. Susceptibility factors of stomach for SARS-CoV-2 and treatment implication of mucosal protective agent in COVID-19. Front Med (Lausanne). 2021;7:597967. [
Link] [
DOI:10.3389/fmed.2020.597967] [
PMID] [
PMCID]
22. Lansbury L, Lim B, Baskaran V, Lim WS. Coinfections in people with COVID-19: A systematic review and meta-analysis. J Infect. 2020;81(2):266-75. [
Link] [
DOI:10.1016/j.jinf.2020.05.046] [
PMID] [
PMCID]
23. Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459-68. [
Link] [
DOI:10.1093/cid/ciaa530] [
PMID] [
PMCID]
24. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial coinfection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622-9. [
Link] [
DOI:10.1016/j.cmi.2020.07.016] [
PMID] [
PMCID]